Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Dai Yuan Ma"'
Autor:
Qing Liu, Xue‐Hua Tu, Rui‐Xuan Yu, Hong‐Ying Wen, Xiao‐Guang Guo, Dai‐Yuan Ma, Kai‐Yuan Jiang, Dong Tian
Publikováno v:
Cancer Medicine, Vol 13, Iss 16, Pp n/a-n/a (2024)
Abstract Background The optimal treatment for esophageal squamous cell carcinoma (ESCC) patients with postoperative recurrence remains controversial. We aimed to evaluate the effects of radiotherapy (RT) and chemoradiotherapy (CRT) on postoperative r
Externí odkaz:
https://doaj.org/article/fa2c07fb89834b3f8dfc21628b54c968
Autor:
Yang Shen, Yuan Qiu, Zhen-quan Duan, Yu-xian Li, Ying Wang, Yuan-yuan Zhang, Bao-hang Zhu, Xiao-hong Yu, Xue-ling Tan, Weisan Chen, Yuan Zhuang, Quan-ming Zou, Dai-yuan Ma, Liu-sheng Peng
Publikováno v:
Pharmacological Research, Vol 202, Iss , Pp 107122- (2024)
The ectonucleotidase CD39 has been regarded as a promising immune checkpoint in solid tumors. However, the expression of CD39 by tumor-infiltrating CD8+ T cells as well as their potential roles and clinical implications in human gastric cancer (GC) r
Externí odkaz:
https://doaj.org/article/70c96084701b405bbfeb2784adbe514e
Autor:
Zhen‐quan Duan, Yu‐xian Li, Yuan Qiu, Yang Shen, Ying Wang, Yuan‐yuan Zhang, Bao‐hang Zhu, Xiao‐hong Yu, Xue‐ling Tan, Weisan Chen, Yuan Zhuang, Ping Cheng, Wei‐jun Zhang, Quan‐ming Zou, Dai‐yuan Ma, Liu‐sheng Peng
Publikováno v:
Clinical & Translational Immunology, Vol 13, Iss 3, Pp n/a-n/a (2024)
Abstract Objectives CD4+ T cell helper and regulatory function in human cancers has been well characterised. However, the definition of tumor‐infiltrating CD4+ T cell exhaustion and how it contributes to the immune response and disease progression
Externí odkaz:
https://doaj.org/article/f8e3cfb8a8bd4a588f3f390e44bc9e14
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 238-246 (2020)
Abstract Background To compare the survival outcomes and neurocognitive dysfunction in non‐small cell lung cancer (NSCLC) patients with brain metastases (BM ≤10) treated by whole‐brain radiotherapy (WBRT) with sequential integrated boost (SEB)
Externí odkaz:
https://doaj.org/article/d364e83e92d44d9ba96aeb2fc658d60b
Primary cardiac angiosarcoma (PCA) is a relatively rare and fatal disease with poor prognosis. It remains controversial whether its survival can be improved with additional treatment besides complete surgical excision. In this case,we presented a 52-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cba5ef7eb6ae6aaf7d7f280eed009b1
https://doi.org/10.21203/rs.3.rs-2788054/v1
https://doi.org/10.21203/rs.3.rs-2788054/v1
Publikováno v:
Journal of Thoracic Oncology. 18:S24-S25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d233106719c54e9e8e0a0aac8e9b2979
https://doi.org/10.1016/j.jtho.2023.01.068
https://doi.org/10.1016/j.jtho.2023.01.068
Publikováno v:
Open Medicine. 17:2046-2051
Although the incidence of multiple primary malignancies (MPMs) is increasing, synchronous triple primary malignant tumours with prostate, bladder and lung is rarely reported. Gene mutation is thought to be a reason for MPMs, and severe cardiovascular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7851ce69bd10db2dacfb31baa66e2839
https://doi.org/10.1515/med-2022-0616
https://doi.org/10.1515/med-2022-0616
Publikováno v:
Open Life Sciences. 18
Primary malignant melanoma of the parotid gland (PGMM) is extremely rare, with a poor prognosis. Surgery is the main treatment option followed by adjuvant treatments such as radiotherapy, but which adjuvant treatment to be optimal is still controvers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf102f0151f06314cfc65f2be6f6e641
https://doi.org/10.1515/biol-2022-0555
https://doi.org/10.1515/biol-2022-0555
Autor:
Ping Cheng, Yu-xian Li, Weisan Chen, Liu-sheng Peng, Yuan Qiu, Jin-yu Zhang, Zhuo Zhao, Yong-liang Zhao, Quanming Zou, Xiao-long Li, Yuan Zhuang, Zhi-Guo Shan, Dai-yuan Ma, Yang Shen
Publikováno v:
Cancer Immunology, Immunotherapy. 71:1645-1654
CD8+CD103+ tissue-resident memory T cells (TRMs) are involved in tumor immune response and linked to favorable clinical outcome in human cancer. However, the distribution, phenotype, functional properties and clinical relevance of these cells in gast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95eb2a30e14e5f3274cc58913e5817a6
https://doi.org/10.1007/s00262-021-03105-0
https://doi.org/10.1007/s00262-021-03105-0
Autor:
Maoqiong Jiang, Min Yu, Meijuan Huang, Jiang Zhu, Qiang Zhou, Juan Li, Zhiyu Lin, Dai-Yuan Ma, Lin Chen, You Lu, Shubin Tang, Tian Tian, Youling Gong
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundData on the use of immune checkpoint inhibitors (ICIs) in advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutation are limited. The current study aimed to assess the efficacy of ICIs in EGFR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45cdef1dff214cf27280bbff403e0416
https://doi.org/10.3389/fonc.2021.739090
https://doi.org/10.3389/fonc.2021.739090